| Literature DB >> 26029083 |
Maximilian J Wessel1, Máximo Zimerman2, Friedhelm C Hummel3.
Abstract
Stroke is the leading cause of disability among adults. Motor deficit is the most common impairment after stroke. Especially, deficits in fine motor skills impair numerous activities of daily life. Re-acquisition of motor skills resulting in improved or more accurate motor performance is paramount to regain function, and is the basis of behavioral motor therapy after stroke. Within the past years, there has been a rapid technological and methodological development in neuroimaging leading to a significant progress in the understanding of the neural substrates that underlie motor skill acquisition and functional recovery in stroke patients. Based on this and the development of novel non-invasive brain stimulation (NIBS) techniques, new adjuvant interventional approaches that augment the response to behavioral training have been proposed. Transcranial direct current, transcranial magnetic, and paired associative (PAS) stimulation are NIBS techniques that can modulate cortical excitability, neuronal plasticity and interact with learning and memory in both healthy individuals and stroke patients. These techniques can enhance the effect of practice and facilitate the retention of tasks that mimic daily life activities. The purpose of the present review is to provide a comprehensive overview of neuroplastic phenomena in the motor system during learning of a motor skill, recovery after brain injury, and of interventional strategies to enhance the beneficial effects of customarily used neurorehabilitation after stroke.Entities:
Keywords: TMS; motor learning; motor recovery; neurorehabilitation; non-invasive brain stimulation; stroke; tDCS
Year: 2015 PMID: 26029083 PMCID: PMC4432668 DOI: 10.3389/fnhum.2015.00265
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Figure 1Conceptual components in motor learning. The illustrated learning curve indicates the increase in motor skill over time. Online – within-session learning. Offline – in-between-session learning. Fast learning – single-session practice. Slow learning – multiple-session practice. Consolidation – offline-improvement and memory stabilization. Long-term retention – skill retention after a prolonged interval. Savings – impact of previous learning on faster retraining, expressed in an increased slope f′(x) of the learning curve. For a detailed description, please see text.
Summary of the sham-controlled studies performed with non-invasive brain stimulation in motor recovery after stroke.
| Number of patients | Cortical/subcortical | Ischemic/hemorrhagic | Severity of stroke | Stroke duration | Motor assessments and outcomes | Concomitant therapy | Study design | NIBS Intervention | Number of sessions | Follow-ups | Result | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Khedr et al. ( | 52 | Cortico-subcortical | Ischemic | Moderate to severe | 5–10 days | SSS, NIHSS, BI | Standard physical therapy | Randomized, parallel groups | 3 Hz rTMS over iM1 | 10 days | 10 days | Pos |
| Mansur et al. ( | Stroke 10, healthy 6 | Cortico-subcortical | Ischemic | Mixed | <12 months | sRT, cRT, PP, FT | NA | Randomized, cross-over | 1 Hz rTMS over cM1 and cPM | One | NA | Pos |
| Takeuchi et al. ( | 20 | Subcortical | Ischemic | Mixed | 26.95 months | FM, PA | NA | Randomized, parallel groups | 1 Hz rTMS over cM1 | One | NA | Pos |
| Fregni et al. ( | 15 | Cortical 1, subcortical 13, cortico-subcortical 1 | Ischemic | Mild to moderate | 44.05 months | MRC, ASS, JTT, sRT, cRT, PPT | NA | Randomized, parallel groups | 1 Hz rTMS over cM1 | 5 days | 2 weeks | Pos |
| Kim et al. ( | 15 | Cortical 5, subcortical 10 | Ischemic 12, hemorrhagic 3 | Mild to moderate | 16.7 months | PP, GF, FT | FT | Randomized, cross-over | 10 Hz rTMS over iM1 | One | NA | Pos |
| Liepert et al. ( | 12 | Subcortical (2 pons) | NM | Mild | 7.3 days | MRC, GF, NHPT | NA | Randomized, cross-over | 1 Hz rTMS over cM1 | One | NA | Pos |
| Malcolm et al. ( | 20 | Cortico-subcortical | Hemorrhagic 1 | Mixed | 45.6 months | WMFT, BBT, MAL | CIT | Randomized, parallel groups | 20 Hz rTMS over iM1 | 10 days | 6 months | Neg |
| Talelli et al. ( | 6 | Cortical 3, subcortical 3 | Ischemic | Mild to moderate | 31 months | BI, NIHSS, ARAT, 9HP, GF, sRT, cRT | NA | Randomized, cross-over | iTBS over iM1, cTBS over cM1 | One | NA | Pos |
| Dafotakis et al. ( | 12 | Subcortical | Ischemic | Mild | 1.88 months | MRC (4–5), NIHSS, ARAT, grip-lift task | Grasping and lifting | Randomized, cross-over | 1 Hz rTMS over cM1 | One | NA | Pos |
| Mally and Dinya ( | 64 | Cortical, large | Ischemic, hemorrhagic 18 | Severe | 129.6 months | Spasticity score | NA | Randomized, parallel groups | 1 Hz rTMS over cM1 and iM1 | 7 days | 3 months | Pos |
| Nowak et al. ( | 15 | Subcortical | Ischemic | Mild | 1.93 months | ARAT, MRC (4–5), FT, reach to grasp | NA | Randomized, cross-over | 1 Hz rTMS over cM1 | One | NA | Pos |
| Takeuchi et al. ( | 20 | Subcortical | Ischemic | Mixed | 29.9 months | FM, acceleration and PF | PF training | Randomized, parallel groups | 1 Hz rTMS over cM1 | One | 1 week | Pos |
| Ameli et al. ( | 29 | Cortical 13, subcortical 16 | Ischemic | Mild to moderate | 5.5 months | MRC, ARAT, mRS, NIHSS, index finger and hand tapping | NA | Randomized, cross-over | 10 Hz rTMS over iM1 | One | NA | Mix |
| Khedr et al. ( | 36 | Cortical 19, subcortical 17 | Ischemic | Mild to moderate | 0.57 months | MRC, NIHSS, BI, tapping, PP | NA | Randomized, parallel groups | 1 Hz rTMS over cM1, 3 Hz over iM1 | Five | 3 months | Pos |
| Takeuchi et al. ( | 30 | Subcortical | Ischemic | Mixed | 28.8 months | FM, acceleration and PF | Motor training (pinching task) | Randomized, parallel groups | 1 Hz rTMS over cM1, 10 Hz over iM1, bilateral rTMS | One | 1 week | Pos |
| Chang et al. ( | 28 | Cortical 11, subcortical 17 | NM | Moderate to severe | 13.4 days | MI, FM, GF, BB | Reaching and grasping exercises | Randomized, parallel groups | 10 Hz over iM1 | 10 | 3 months | Pos |
| Emara et al. ( | 60 | Cortical 43, subcortical 17 | Ischemic | Mild to moderate | >1 month | FT, mRS, AI | Standard physical therapy | Randomized, parallel groups | 5 Hz rTMS over iM1, 1 Hz rTMS over cM1 | Ten | 12 weeks | Pos |
| Grefkes et al. ( | 11 | Subcortical | Ischemic | Mild | 1.91 months | MRC (4–5), ARAT, NIHSS, whole hand fist task | NA | Randomized, cross-over | 1 Hz rTMS over cM1 | One | NA | Pos |
| Avenanti et al. ( | 30 | Cortical 3, cortico-subcortical 1, subcortical 26 | Ischemic 20, hemorrhagic 10 | Mild | 31.47 months | JTT, NHPT, BB, PF | Standard physical therapy | Randomized, parallel groups | 1 Hz rTMS over cM1 | 10 | 3 months | Pos |
| Chang et al. ( | 17 | Cortical 2, subcortical 15 | Ischemic 14, hemorrhagic 3 | Mild to moderate | >3 months | JTT, SFTT | SFTT | Randomized, parallel groups | 10 Hz rTMS over iM1 | 10 | 1 month | Pos |
| Conforto et al. ( | 30 | Subcortical 16, cortical 14 | Ischemic | Mild to severe | 0.92 months | MRC, NIHSS, JTT, PF | Standard physical therapy | Randomized, parallel groups | 1 Hz rTMS, over cM1 | 10 | 1 month | Pos |
| Seniow et al. ( | 40 | Cortical 16, subcortical 14 | Ischemic 35, hemorrhagic 5 | Moderate | <3 months | WMFT, NIHSS, FM | Standard physical therapy | Randomized, parallel groups | 1 Hz over cM1 | 3 weeks | 3 months | Neg |
| Wang et al. ( | 28 | NM | NM | Moderate | >6 months | FM, WP | Task-oriented training | Randomized, parallel groups | 1 Hz rTMS over cM1 | Ten | NA | Pos |
| Etoh et al. ( | 18 | Cortical 1, subcortical 17 | Ischemic 13, hemorrhagic 5 | Severe | 29.9 months | FM, ARAT, MAS | Physical or occupational therapy | Randomized, cross-over | 1 Hz rTMS over cM1 | Ten | 4 weeks | Pos |
| Higgins et al. ( | 11 | NM | NM | Mild to severe | >3 months | BB, WMFT, MAL, GF, PF, SIS | Task-Oriented Training | Randomized, parallel groups | 1 Hz TMS over cM1 | Eight | NA | Neg |
| Sasaki et al. ( | 29 | Subcortical | Ischemic 13, hemorrhagic 16 | Mild to moderate | 0.58 months | NIHSS, GF, FT | Standard physical therapy | Randomized, parallel groups | 10 Hz rTMS over iM1, 1 Hz rTMS over cM1 | Five | NA | Pos |
| Sung et al. ( | 54 | Cortical 35, subcortical 19 | Ischemic 35, hemorrhagic 19 | Severe | 3–12 months | GF, FM, WMST, RT | NA | Randomized, parallel groups | 1 Hz rTMS over cM1/iTBS over iM1 | 20 | NA | Pos |
| Brodie et al. ( | 15 | Cortico-subcortical 5, subcortical 9 | NM | Mild to moderate | >6 months | STT, 2PD, WMFT, BB, GF | STT | Randomized, parallel groups | 5 Hz rTMS over iS1 | Five | 1 day | Mix |
| Rose et al. ( | 19 | NM | Ischemic | Moderate | >6 months | WMFT, FM, ARAT, GF, PF, MAS, MAL | Functional Task Practice | Randomized, parallel groups | 1 Hz rTMS over cM1 | 16 | 30 days | Neg |
| Motamed Vaziri et al. ( | 12 | NM | NM | Severe | >2 months | BI, FM | Standard physical therapy | Randomized, parallel groups | 1 Hz rTMS over cM1 | 10 | NA | Pos |
| Wang et al. ( | 44 | Cortical 16, subcortical 28 | Ischemic 29, hemorrhagic 15 | Moderate to severe | 3–12 months | MRC, FM, WMFT | Standard physical and occupational therapy | Randomized, parallel groups | 1 Hz rTMS over cM1, 1 Hz rTMS over cPMd | 10 | NA | Pos |
| Fregni et al. ( | 6 | Cortico-subcortical | NM | Mild to moderate | 27.1 months | MRC, ASS, JTT | NA | Randomized, double-blinded, cross-over | ctDCS over cM1 and atDCS over iM1 | One | NA | Pos |
| Hummel et al. ( | 6 | Subcortical 5, cortico-subcortical 1 | Ischemic | Mild | 44.4 months | MRC, FM, ASS, JTT | NA | Randomized, double-blinded, cross-over | atDCS over iM1 | One | 10 days | Pos |
| Hummel et al. ( | 11 | Subcortical | Ischemic | Mild to moderate | 41.8 months | MRC, FM, ASS, sRT, PF | NA | Randomized, double-blinded, cross-over | atDCS over iM1 | One | NA | Pos |
| Boggio et al. ( | 9 | Subcortical | NA | Mild to moderate | 40.9 months | MRC, JTT, ASS | NA | Randomized, double-blinded, cross-over | ctDCS over cM1 and atDCS over iM1 | 5 days | 2 weeks | Pos |
| Kim et al. ( | 18 | Cortical 5, subcortical 9, cortico-subcortical 4 | Ischemic | Mixed | 25.6 days | MRC (2–5) and FM (16–60), FM, BI | Occupational therapy | Randomized, parallel groups | ctDCS over cM1, atDCS over iM1 | 10 | 6 months | Mix |
| Lindenberg et al. ( | 20 | Cortico-subcortical | Ischemic | Severe | 35.4 months | FM (20–56), WMF | Occupational therapy | Randomized, parallel groups | Bilateral tDCS | Five | 1 week | Pos |
| Bolognini et al. ( | 14 | Cortical 9, cortico-subcortical 5 | Ischemic 12, hemorrhagic 2 | Moderate to severe | 35.21 months | FM, BI, JTT, HG, MAL | CIT | Randomized, parallel groups | Bilateral tDCS | 10 | 4 weeks | Pos |
| Hesse et al. ( | 96 | Mixed cortico-subcortical | Ischemic | Severe | 0.93 months | BI, FM (<18), BB, MAS, MRC | Robot-assisted arm training | Randomized, parallel groups, multicenter | ctDCS over cM1 and atDCS over iM1 | 30 (6 weeks) | 3 months | Neg |
| Madhavan and Stinear ( | 9 | Cortico-subcortical | NA | Lower extremity | 130.8 months | FM-LE, dorsiflexion and plantar flexion movements | Tracking dorsiflexion and plantar flexion task | Randomized, cross-over | atDCS over iM1, atDCS over cM1 | One | NA | Pos |
| Nair et al. ( | 14 | Cortical 9, subcortical 5 | NA | Moderate to severe | 31 months | FM (30.1) | Occupational therapy | Randomized, parallel groups | ctDCS over cM1 | Five | 1 week | Pos |
| Tanaka et al. ( | 8 | Subcortical | NA | Mixed, lower extremity | 21.1 months | SIAS, knee extension, GF | Force knee extension | Randomized, cross-over | atDCS over iM1 | One | NA | Pos |
| Stagg et al. ( | 17 | Cortical and subcortical | Ischemic 16, hemorrhagic 1 | Mixed | 37.9 months | FM, GF, response time task | NA | Randomized, double-blinded, cross-over | ctDCS over cM1 and atDCS over iM1 | One | NA | Pos |
| Zimerman et al. ( | 12 | Subcortical | Ischemic | Mild | 30 months | MRC, FM, ASS, FT | SFTT | Randomized, double-blinded, cross-over | ctDCS over cM1 | One | 3 months | Pos |
| Danzl et al. ( | 8 | NM | Ischemic 6, hemorrhagic 2 | Moderate | 1.1– 11.6 years | 10 MWT, TUG, BBS, FAC, SIS | RGO-locomotor training | Randomized, double-blind, sham-controlled | atDCS over iM1 | 12 | 1 month | Pos |
| Giacobbe et al. ( | 12 | NM | NM | Moderate | >6 months | MRC | Robotic motor practice | Block-randomized, sham-controlled | atDCS over iM1 | Four | NA | Mix |
| Khedr et al. ( | 40 | Cortical 18, cortico-subcortical 8, subcortical 14 | Ischemic | Moderate | Anodal 13.8 ± 5.8, cathodal 12.3 ± 4.4, sham 12.6 ± 4.6 days | NIHSS, OMCASS, BI, MRC | Occupational therapy within 1 h after stimulation | Single-center, randomized, double-blind, sham-controlled | atDCS over iM1, ctDCS over cM1 | 6 days | 1–3 months | Pos |
| Lefebvre et al. ( | 18 | Cortical 11, subcortical 7 | Ischemic 16, hemorrhagic 2 | Moderate | 2.6 ± 1.5 years | PP, GF | Visuomotor learning task | Randomized, cross-over, sham-controlled, double-blind | Dual-tDCS | One | 1 week | Pos |
| Rossi et al. ( | 50 | Cortical 3, cortico-subcortical 35, subcortical 12 | Ischemic | Moderate to severe | 2 days | FM, NIHSS | NA | Single-center, randomized, double-blind, sham-controlled | atDCS over iM1 | Five | 5 days, 3 months | Neg |
| Sohn et al. ( | 11 | Subcortical | Ischemic 4, hemorrhagic 7 | Severe | 63.00 ± 17.27 days | Static postural stability, isometric strength | NA | Randomized, cross-over, sham-controlled | atDCS over iM1 | Two | NA | Mix |
| Au-Yeung et al. ( | 10 | NM | Ischemic 8, hemorrhagic 2 | Mild to moderate | 8.3 ± 3.2 years | PP, Stroop test | NA | Double-blind, sham-controlled, randomized, cross-over | atDCS over iM1, ctDCS over cM1 | Three | NA | Mix |
| Fusco et al. ( | 11 | NM | Ischemic | Mixed | <30 days | CNS, BI, 9HPT, FM, TUG, 10MWT, 6MWT, RMI, FAC | Rehabilitative training | Double-blind, randomized, sham-controlled | ctDCS over cM1 | 10 | 30, 75–110 days | Neg |
| Lefebvre et al. ( | 19 | Cortical 8, subcortical 11 | Ischemic 17, hemorrhagic 2 | Moderate | 4 ± 2 years | PP, PG | NA | Randomized, cross-over, sham-controlled, double-blind | Dual-tDCS | One | NA | Pos |
| O’Shea et al. ( | 13 | Cortical 6, subcortical 7 | Ischemic 12, hemorrhagic 1 | Moderate | 1.5–5.8 years | sRT, FM, WMFT | NA | Cross-over, sham-controlled, single-blind | atDCS over iM1, ctDCS over cM1, Dual-tDCS | One | NA | Mix |
| Tahtis et al. ( | 14 | Cortical 6, subcortical 8 | Ischemic | Moderate | 2–8 weeks | TUG | NA | Double-blinded, sham-controlled, parallel design | Bi-cephalic tDCS | One | NA | Mix |
| Viana et al. ( | 20 | NM | Ischemic 19, hemorrhagic 1 | Moderate | Anodal 31.9 ± 18.2, sham 35 ± 20.3 months | FM, WMFT, ASS, GF | Virtual reality therapy | Randomized, double-blind, sham-controlled | atDCS over iM1 | 15 | 5 weeks | Neg |
10MWT, 10 Meter Walk Test; 2PD, 2-point discrimination; 6MWT, Six-Minute Walking Test; 9HP, 9-holepeg Test; AI, Activity Index score; ARAT, Action Research Arm Test; ASS, Ashworth Spasticity Scale; BB, Box and Block Test; BBS, Berg Balance Scale; BI, Barthel Index; CIT, constrain-induced therapy; cM1, contralesional motor cortex; CNS, Canadian Neurological Scale; cPM, contralesional premotor cortex; cRT, choice reaction time task; FAC, functional ambulation category; FM, Fugl–Meyer Scale; FT, finger-tapping task; GF, grip force; iM1, ipsilesional motor cortex; JTT, Jebsen–Taylor Hand Function Test; MAL, motor activity log; MAS, Modified Ashworth Spasticity Scale; MI, motoricity index; Mix, mixed result; MRC, Medical Research Council; mRS, modified Ranking Scale; NA, not applicable; Neg, negative result; NIHSS, NIH Stroke Scale; NM, not mentioned; OMCASS, Orgogozo’s MCA scale; PA, pinch acceleration; PF, pinch force; PG, precision grip; Pos, positive result; PP, Purdue Pegboard Test; RMI, Rivermead Mobility Index; S1, primary sensory cortex; SFTT, sequential finger-tapping task; SIAS, Stroke Impairment Assessment Set; SIS, Stroke Impact Scale 16; sRT, simple reaction time task; SSS, Scandinavian Stroke Scale; STT, serial tracking task; TUG, Timed Up and Go Test; WMFT, Wolf Motor Function Test; WP, walking performance.
Figure 2Proposed strategies to increase the effect of non-invasive brain stimulation (NIBS) in motor recovery after stroke. iM1, ipsilesional primary motor cortex; cM1, contralesional primary motor cortex; PMC, premotor cortex; tDCS, transcranial direct current stimulation; rTMS, repetitive transcranial magnetic stimulation; TBS, theta-burst stimulation; PAS, paired associative stimulation.
Pros and cons of potential strategies for increasing the effect of non-invasive brain stimulation.
| Strategy | Pros | Cons |
|---|---|---|
| Stimulation of iM1 | • Direct enhancement of the reduced participation in the incompletely recovered motor network after stroke | • Higher risk of adverse effects due to induction of excitotoxicity in the penumbra and shunting of electrical current |
| Stimulation of cM1 | • Stimulation of intact cortical areas | • Inhibitory stimulation might also impair complex motor function |
| Stimulation of secondary sensorimotor areas | • Stimulation of intact cortical areas | • More difficult to target |
| • Modulation of cortico-cortical connections to M1 | ||
| Stimulation of the cerebellum | • Stimulation of intact cortical areas | • More difficult to target |
| • Alternative target within the motor learning network | • Comparable high discomfort of cerebellar rTMS protocols | |
| Simultaneous application of a motor training paradigm | • Simultaneous modulation of LTP-/LTD-like mechanisms | • Unfavorable homeostatic interactions |
| • Not feasible for most rTMS protocols | ||
| Stimulation in the acute or sub-acute phase | • Enhanced adaptive plasticity | • Higher risk of adverse effects |
| Stimulation in the chronic phase | • More stable deficit | • Reestablished growth/plasticity inhibition |
| • Lower risk of adverse effects | ||
| Multi-session stimulation | • Enhancement of plasticity, e.g., induction of late-phase LTP/LTD-like neuroplasticity | • More complex and time-consuming |
| Multifocal stimulation | • Modulation of multiple nodes of the motor network | • Higher risk of adverse effects, e.g., shunting of current |
| • Induction of additive or supra-additive effects | ||
| Sequential stimulation | • Time-dependent modulation of multiple nodes of the motor network | • More complex setup |
| Patterned rTMS protocols | • Shorter delivery time | • Higher risk of adverse effects |
| • Proposed potent modulatory aftereffect | • Need of a more complex and expensive setup | |
| • Mixed results |